Kindred Ventures
Based on the provided context, Kindred Ventures has launched Fund III with $130M to invest in tech startups at the pre-seed stage. Their strategy involves backing innovative companies at the earliest stages of development.
Knoll Ventures
Knoll Ventures is a strategic capital provider for early-stage technology companies, specifically those in the B2B space. They aim to back "outliers" – creative thinkers, change-makers, and innovators who challenge the status quo. Based in Atlanta, GA, the firm focuses on Pre-Series A investments, recognizing the unique challenges faced by founders at this critical stage. They strive to be the first call founders make when seeking actionable advice, emphasizing a long-term perspective in their partnerships. Their investment approach involves leading or co-leading rounds ranging from $500,000 to $3,000,000 in B2B technology-enabled companies at the pre-seed, seed, and post-seed stages. Knoll Ventures looks for passionate founders with a clear understanding of customer pain points and a compelling vision for the future. They focus on aligning themselves with founders through a deep understanding of round objectives and a scalable investment structure. The firm's commitment extends beyond just writing a check, with a focus on adding value through growth strategy execution, strategic introductions to their network, and support for follow-on fundraising. They actively involve themselves in round objective setting, alignment of interests, and syndicate construction prior to investment. Post-investment, they provide guidance on growth strategy execution, facilitate strategic introductions, and assist with follow-on fundraising. Knoll Ventures emphasizes the importance of making meaningful connections for their portfolio companies, particularly during the critical early stages. By specializing in Pre-Series A companies, they have developed a unique perspective on the challenges founders face at this stage and aim to provide tailored support and guidance. They closed their second fund in Spring 2022 to further support founders at the earliest stages of growth.
Korpun Siemen Oy
Korpun Siemen Oy is a seed-stage investment firm that invests in early-stage startups, typically deploying between €50,000 and €200,000, as part of a larger €200,000 to €500,000 financing round. They have no specific industry or geographic restrictions and always co-invest with existing investors, seed-stage investment companies, funds, and angel investors. They look for companies with existing turnover/contracts and a ready first version of their product/service, emphasizing experienced teams with industry expertise. Their model aims to solve problems faced by startups seeking financing, such as missing the "last" portion of a funding round. Korpun Siemen seeks to be that final piece by co-investing with a lead investor. They also address the diversification challenges faced by angel investors, providing access to a broader network and more investment opportunities via their 33 active investors, who have combined their investment activities. These investors include angel investors, entrepreneurs, and individuals who have already exited companies, bringing diverse experience across various industries. The firm also helps startups avoid the constant need to seek new investors as they grow by making direct follow-up investments in subsequent rounds. Korpun Siemen distinguishes itself by offering a unique combination of early-stage funding with the backing of experienced investors who can also participate in later rounds. This approach seeks to alleviate the pressure on growth companies to constantly seek new investors at each stage. They collaborate with Mint Palvelut (formerly SijoittajaPRO Corporate Finance) in evaluating companies and making further investments, leveraging a track record of over €60 million invested in over 70 later-stage companies through SijoittajaPRO CF. By extending their operations to early-stage companies via Korpun Siemen, they are providing a comprehensive investment strategy that can support companies throughout their growth trajectory. The firm leverages their investors' networks and expertise to evaluate investment targets, providing startups with not only capital but also access to valuable resources and connections. Their focus is on being the final piece of a funding round, co-investing with lead investors, and offering support beyond the initial investment through follow-on rounds and collaboration with other VC funds.
Kost Capital
Kost Capital is a venture capital fund investing in companies shaping the nutrition transition. They aim to build the industrial backbone that makes trends viable & profitable by combining industrial logic, automation, and M&A to build scalable, resilient, and profitable platforms. They focus on ambitious capital and a founder's mindset, bringing experience from building VCs, scale-ups, and large multinational companies. Their approach redesigns venture capital for food, prioritizing investments in passionate entrepreneurs at the forefront of science and technology, emphasizing ideas and founders over just numbers and metrics. They also have a studio focusing on food development, working in the intersection of culture, academia, and business. They are passionate about using their expertise to help founders build impactful companies. Kost Studio also focuses on research and development related to new products in the plant based food space.
LVP
LVP positions itself as a key partner for AI founders, particularly those building foundational AI technologies. The firm emphasizes a commitment to long-term partnerships with founders, demonstrated by their continued investments in companies like Anthropic. The firm prioritizes supporting companies that have the potential to significantly impact the world, with a focus on innovation and scaling intelligence responsibly. They aim to be the 'first call' for AI founders, suggesting a strong network and established expertise in the AI sector. Their strategy involves identifying and backing companies early on, often at the seed or Series A stage, and then providing ongoing support as they grow.
LYVA Labs
LYVA Labs drives economic growth through innovation by supporting startups and SMEs in health, life sciences, clean tech, and deep tech. Focuses on pre-seed investment, incubation, acceleration, and grant-funded innovation programs to foster scalable, impactful solutions within Liverpool City Region.
La Famiglia VC
La Famiglia is a European seed and growth stage venture capital fund that invests in technology companies enabling or disrupting large industries. They differentiate themselves by offering more than just capital; they act as a trusted access platform, creating unique relationships between established industries and innovative startups. This access platform provides portfolio companies with early market access, impactful partnerships, and deep expertise, leveraging the connections and experience of their network of world-leading entrepreneurs. Their investment strategy focuses on facilitating relationships between the 'old' and 'new' worlds, indicating a focus on companies that can bridge the gap between traditional industries and emerging technologies. This approach suggests they look for startups that can offer innovative solutions to challenges faced by established businesses, or those that can create entirely new markets by leveraging existing industry infrastructure and knowledge. By building a strong network of successful entrepreneurs, La Famiglia provides its portfolio companies with unparalleled access to mentorship, strategic guidance, and potential business opportunities. They aim to offer differentiated leverage on capital by creating an ecosystem where portfolio companies can benefit from the collective experience and resources of their investors and network. This hands-on approach suggests that La Famiglia actively works to support its portfolio companies beyond just financial investment.
Lanai Partners
Lanai Partners positions itself as an "entrepreneurs’ community VC" aiming to back Spain’s most ambitious founders. They emphasize a hands-on approach, leveraging their experience as founders and operators to advise and support their portfolio companies. Their focus is on investing in founders rather than just projects, looking for winning teams and supporting them in achieving their goals. They are proud industry agnostics, demonstrating a willingness to invest across various verticals. They bring over 15 years of entrepreneurial experience, having founded multiple companies generating over €100m in annual revenues and employing over 500 people, and leverage this operational know-how to add value to their investments. Lanai Partners was launched in 2017 and has built a portfolio of over 50 companies. They are committed to being a partner in the early stages of the entrepreneurial journey, specifically at the pre-seed stage. The firm's website highlights the significant impact their portfolio companies have collectively achieved, including generating over €1 billion in revenue, raising more than €2 billion in capital, and employing over 15,000 employees. This showcases their ability to identify and support high-growth potential startups. They also emphasize their experience working together as founders and operators for 12 years. The partners' backgrounds include significant roles at companies like Airbnb, Uber, and KPMG, demonstrating their diverse experiences and networks, which they use to support their portfolio. They not only bring financial investment, but also offer strategic guidance, operational expertise, and access to a wide network of contacts.
Latitud Ventures
Latitud Ventures focuses on supporting startups in Latin America from the very early stages, "from inception to conviction." They aim to provide initial funding to help founders build an MVP and validate their hypotheses. They appear to be backing LatAm-born founders conquering the globe. The firm also runs a Fellowship program to help refine startup ideas, provide access to a community of founders and exclusive content. They invest in the pre-seed stage and are proud to be the first check into companies.
Laton Ventures
Laton Ventures is a gaming and apps-focused venture capital firm backed by over 35 successful gaming industry veterans. They invest in early-stage (pre-seed and seed) gaming and apps companies worldwide, spanning mobile, cross-platform, and AI-enhanced experiences. The firm aims to level up its portfolio companies to new heights by providing unparalleled operational support in key areas such as game design, product management, marketing (user acquisition), and HR. They leverage a deep industry network to connect portfolio companies with prominent gaming and apps VCs and industry players globally. Laton Ventures emphasizes genuine connections with visionary and passionate teams, focusing on unlocking new horizons together.
Latvian Business Angels Network (LatBAN)
LatBAN is a network of angel investors focused on connecting angel investors with startups demonstrating exceptional growth potential. They aim to be a leading force in the Latvian startup ecosystem by providing business angels the opportunity to invest in promising startups, and enabling startups to receive capital for growth. LatBAN fosters a community for local business angels to gain access to a dealflow of promising startup companies and promotes experience sharing, education, and collaboration. The investment strategy is centered around early-stage companies, specifically those seeking initial funding to scale. They look for startups with innovative projects both in Latvia and abroad and provide them with not just capital but also the expertise and time of experienced business professionals. This hands-on approach suggests a value-add strategy beyond just providing capital. The firm's approach is community-driven, seeking to connect experienced business angels with visionary entrepreneurs. This facilitates a dynamic network where ideas are nurtured, and ventures are shaped. They position themselves as a backstage pass to a vibrant community, implying a focus on supporting the startup ecosystem through active engagement and collaboration amongst its members. LatBAN focuses on creating a supportive network where angel investors can access a dealflow of promising companies and benefit from shared experience and collaborative learning. Their investment strategy seems to be a balanced approach of providing financial resources and mentorship/expertise to the startups that they back.
Launchbay Capital
Launchbay Capital focuses on fostering innovation and liquidity within the technology sector through a combination of secondary investments and direct investment opportunities. They aim to provide essential investments and expertise by leveraging an actively managed secondary growth fund that focuses on high-liquidity investments in growth-stage venture-backed tech companies. Furthermore, they facilitate direct investment access to leading global technology companies in the private markets via the Launchbay investment platform (LBX.pro), also offering tokenized growth equity opportunities. The firm is committed to sourcing attractive deals and scaling businesses from the initial stages of product-market fit, while also designing investment structures that facilitate liquidity windows and capital redistribution. Their approach involves leveraging data analysis to understand the underlying fundamentals of venture businesses, coupled with deep investment expertise to execute deals across all investment stages. Launchbay Capital emphasizes a long-term investment horizon, focusing on risk management strategies that enable investment teams to remain agile and resilient throughout various market cycles. They provide access to curated, tokenized private equity portfolios across transformative industries, offering fractional ownership and simplified investment access. The firm invests across the full venture value chain, providing multiple investment solutions including direct platform opportunities, fund structures, secondaries, and select partnerships with specialized pre-seed and seed VC managers. They appear to have a global outlook and a diverse team, with partners bringing multi-country investment experience, a strong track record, and a broad industry network. Launchbay Capital believes that collaboration and engagement are critical to navigating increasing investment complexities.
Legal and General Capital
Legal and General Capital (L&G Capital) operates within the broader Legal & General Group, focusing on private market investments. Their overarching investment strategy centers on delivering both financial returns and positive social outcomes. They aim to meet the needs of their stakeholders through long-term relationships, and by originating new investment opportunities, using their own balance sheet and managing external capital on behalf of pension schemes and institutional clients. L&G Capital's strategy encompasses a diverse range of private market assets, including real estate equity, private credit, infrastructure equity, and venture capital. Their approach involves active ownership and operation, particularly within real estate. They invest across the UK, Europe, and the US, targeting assets that align with the evolving requirements of a changing world. A significant part of their approach lies in identifying investment opportunities that tackle global challenges and solve real-world problems, especially within the venture capital space. Their investment decisions are informed by a commitment to long-term value creation. The firm leverages its experienced professionals and in-house expertise to identify and manage investments effectively. By investing in diverse sectors and asset classes, L&G Capital seeks to provide its clients with a range of solutions tailored to their specific investment objectives. L&G Capital's engagement in venture capital focuses on capitalizing on technological advancements and innovation, especially within the UK and European markets. They actively seek partnerships with universities and technology companies to identify promising investment opportunities. This approach reflects the firm's broader commitment to supporting growth equity opportunities in real estate and other sectors.
Leksell Social Ventures
Leksell Social Ventures invests in visionary scientific innovations and their implementation, combining entrepreneurial drive with strategic capital to create lasting social impact. They focus on early-stage life science companies (diagnostics, biotech, AI-driven health) and outcomes-driven models that validate and scale evidence-based solutions across society’s pillars (private, public, academia, non-profits).
LifeSpan Vision Ventures
LifeSpan Vision Ventures is a venture capital firm focused on investing in companies developing therapeutics targeting longevity and aging reversal. Their mission is to enable healthy, strong, and vibrant human lifespans past 120 years. The firm's primary areas of interest include the whole body, joints, heart, skin, brain, and muscles. LifeSpan Vision Ventures is particularly interested in backing companies with the potential to create game-changing longevity technologies. The firm seeks to add value through its deep understanding of science and technology, the ability to lead or participate in various investment rounds (founding, seed, angel, early and mid-stage), strong financial market contacts for securing capital through various means (bank lines, follow-on equity and debt financings, and public offerings), proven entrepreneurial business ability to found and lead startups, and relationships with academics, professionals, and institutions to foster collaboration and synergy. Andrew Worden, the Founding Partner, brings decades of experience in launching, managing, planning, analyzing, and investing in public and private companies, particularly in the cleantech markets. His experience at GameChange Solar demonstrates the ability to scale businesses rapidly and successfully. Worden's background also includes experience as an investor with Barron Partners LP, where he oversaw investments in over 170 companies globally. Recent press releases highlight their commitment to investing in rejuvenation technologies. Portfolio companies being featured in the news for promising updates also supports their active involvement in the longevity biotechnology space.
Local Globe Latitude
Based on the limited information available, LocalGlobe Latitude positions itself as a long-term partner for founders, focusing on pre-seed and seed stages. They appear to invest across various sectors, with a portfolio including companies in fintech, insurance, travel, and real estate. Their investment strategy seems to involve both LocalGlobe and Latitude funds, suggesting a possible tiered investment approach based on stage or geography. From their portfolio companies, they may prioritize companies with strong growth potential and innovative solutions. The 'Live at Phoenix Court' section indicates a focus on community and providing value through events and networking.
LocalGlobe VC
Based on the website content provided, LocalGlobe positions itself as a "trusted long-term partner for founders from pre-seed and seed." While a comprehensive investment thesis isn't explicitly stated, the firm seems to prioritize early-stage investments with a focus on providing ongoing support and building lasting relationships with the companies they back. Their involvement in multiple companies across diverse sectors suggests an opportunistic approach within their defined stage and geographic preferences. They also appear to have a strong network, as evidenced by the co-investors they work with and the events they host.
M2care
M2care is a venture studio focused on HealthTech, operating as a team of entrepreneur-investors. They finance, operate, and develop innovations aimed at addressing significant health challenges. Unlike incubators or accelerators, M2care invests its own funds and engages operationally in startups, acting as entrepreneurs in residence alongside project leaders. Their approach involves testing project feasibility, creating startups from innovations, investing funds up to Series A, de-risking projects, allocating human resources, recruiting talent, and facilitating market access. M2care's proactive and collaborative method aims to build solid and promising startups ready to tackle market challenges and seize growth opportunities. They select innovations and build the startups of the future. M2care sources HealthTech "rare gems" to transform them into high-performing startups. Before committing to creating a startup and investing, M2care dedicates time to explore the technological assets, risks, and opportunities of each project. They anticipate challenges related to intellectual property, clinical and regulatory developments, industrialization, and market access. Their focus is on constructing the startup by elaborating a detailed development plan, a clear roadmap, securing necessary funding, and assembling a competent team to execute the project. This is done with active support from an ecosystem of industry experts, entrepreneurs, large corporations, academic networks, and healthcare professionals. M2care invests financially and dedicates time and expertise to the startups, transforming human capital into value. They build a cohesive team with project leaders, providing essential skills to launch and develop initial project stages, and can assume the role of CEO as needed. They remain operationally involved until Series A, adapting to the startup's specific needs and preparing for operational transition. M2care finances the earliest development stages, leveraging non-dilutive funding to establish a solid foundation for future growth. Finally, M2care values each project milestone and identifies suitable co-investors among seed and Series A funds to finance further development phases. They also identify potential acquirers early to prepare strategic exits, ensuring startups are ready to capitalize on market opportunities and maximize impact.
MOC Capital
MOC Capital backs pre-seed and seed stage platforms of tomorrow that democratize market access and enhance efficiency through network effects across Europe.
MaRS IAF
MaRS IAF invests in ambitious founders building globally competitive technology companies in Ontario, providing capital, guidance, networks, and customer access to support growth from day zero through seed stage. The fund operates as an evergreen fund to ensure consistent capital deployment and support for new investments.
Magma Partners
Magma Partners invests in top entrepreneurs in Latin America, focusing on increasing their chances of success. They aim to support founders solving the region's biggest problems by building scalable technology businesses in large markets. While they are known for fintech, insurtech, and marketplaces, they consider themselves a generalist fund. They invest from pre-seed to Series A, aiming to be a first investor but also participating in later rounds if they missed the earlier stages. They utilize a 'Magma Memo' system to efficiently receive and review startup information, focusing on the team, the startup, and its traction. They have invested in 125+ startups with $80M+, and back founders solving Latin America's biggest problems by building scalable, technology businesses in big markets. The firm has built a fully distributed team across Latin America to support entrepreneurs. They provide a team of entrepreneurs and former early employees of Silicon Valley and Latin American startups to support founders on their journeys.
Masia
Masia is a globally connected angel VC fund based in Barcelona. Their investment strategy focuses on early-stage companies (pre-seed and seed) within AI and Frontier Technologies. They aim to be a collaborative and founder-first investor, providing not only capital (€125K-€250K) but also access to their network of founders and LPs for go-to-market, hiring, sales, and fundraising support. Masia spun out from Aldea Ventures, a Fund of Funds backing Europe's best specialized VCs, leveraging this connection to offer warm introductions to later-stage investors. They pride themselves on a fast and direct approach, providing quick decision-making with the rigor of a regulated fund.
Mechanism
Mechanism Capital invests in companies building the next paradigm, focusing on both Deep Tech and Crypto. The firm seeks to "Advance the Frontier - Together," suggesting a collaborative approach with portfolio companies. While the website lacks a detailed explanation of its investment strategy, it highlights a focus on identifying and supporting companies that are pushing the boundaries of innovation in their respective fields.
Meneldor
Meneldor provides investors with the opportunity to co-invest with specialists in early-stage Biotech and Pharma companies, specifically from pre-seed to Phase 2 clinical trials. Recognizing the inherent risks and complexity of the biotech sector, Meneldor emphasizes rigorous due diligence. They conduct thorough scientific analysis of potential portfolio companies. A comprehensive assessment of other critical aspects, including intellectual property, medical need, market size, competition, risk profile, management team, financial requirements, and valuation, is performed, only investing when all selection criteria are met. Their investment strategy relies on a rigorous scientific and commercial assessment of early stage Biotech and Pharma companies. It is implied that they leverage their own internal expertise and/or specialist networks to evaluate the potential of new treatments, drugs and therapeutic approaches. By thoroughly evaluating the scientific merit of a company's technology, along with a comprehensive assessment of the business case, IP, and market opportunity, Meneldor aims to mitigate the risk associated with early stage biotech investments. They seek to provide access to investment opportunities that are typically difficult for individual investors to access directly, partnering with those who possess specialized expertise in biotechnology and pharmaceuticals to select and manage investments in this sector. The firm carefully analyzes the science, intellectual property, management, and other factors of biotech companies before deciding to invest. Once a potential target is vetted, they invite their investors to participate in the investment.